Dexcom Inc (NQ: DXCM )

70.48 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2

...

25 26 27 28 29 30 31 32 Next >

Dexcom Snags A New Diabetes Device Win After Covid-Related Delay

March 14, 2022

Dexcom won out in Europe after the pandemic slowed its G7 CGM.

Via Investor's Business Daily

Dexcom G7 Continuous Glucose Monitoring System Receives European CE Mark

March 14, 2022

DexCom Inc's (NASDAQ: DXCM) Dexcom G7 Continuous Glucose Monitoring (CGM) System has secured European CE Mark for people with diabetes aged two years and older...

Via Benzinga

Could A Simple Device Help Revolutionize Medical Diagnostics? This Company Thinks So

March 04, 2022

Image provided by Know Labs This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Know...

Via Benzinga

DexCom's Glucose Monitoring System Snags Breakthrough Device Tag For Hospital Use

March 02, 2022

The FDA granted Breakthrough Device Designation for DexCom Inc (NASDAQ: DXCM) for continuous glucose monitoring (CGM) use in the hospital setting. Dexcom CGM...

Via Benzinga

Dexcom Announces Upcoming Virtual Conference Presentations

February 14, 2022

From DexCom, Inc.

Via Business Wire

DexCom Stock Falls As Q4 Profit, FY22 Sales Outlook Trail Wall Street Estimates

February 11, 2022

DexCom Inc's (NASDAQ: DXCM)

Via Benzinga

Earnings Scheduled For February 10, 2022

February 10, 2022

Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.

Via Benzinga

What 5 Analyst Ratings Have To Say About DexCom

February 03, 2022

Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) within the last quarter:

Via Benzinga

The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO

February 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...

Via Benzinga

Recap: DexCom Q4 Earnings

February 10, 2022

DexCom (NASDAQ:DXCM) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DexCom missed estimated earnings by...

Via Benzinga

Dexcom Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 10, 2022

From DexCom, Inc.

Via Business Wire

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

February 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Where DexCom Stands With Analysts

January 07, 2022

Over the past 3 months, 6 analysts have published their opinion on DexCom (NASDAQ:

Via Benzinga

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

Dexcom G6 Continuous Glucose Monitoring System Now Covered in Alberta for Children and Youth Living With Diabetes

February 03, 2022

From Dexcom, Inc.

Via Business Wire

DexCom: This Life Saving Tech Could Double Your Money In Two Years

December 26, 2021

Despite a global rise in variants of COVID-19, one of last year’s hottest plays on the pandemic shutdowns is getting absolutely slaughtered this year.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022

February 03, 2022

Upgrades BTIG upgraded the previous rating for Insulet Corp (NASDAQ:PODD) from Neutral to Buy. For the third quarter, Insulet had an EPS of $0.18, compared to year-ago...

Via Benzinga

7 Best Mutual Funds to Buy for February

January 28, 2022

Mutual funds are generally considered less risky. Here are seven mutual funds tailored to different investment objectives and risk profiles.

Via InvestorPlace

Dexcom Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for February 10, 2022 at 4:30 p.m. Eastern Time.

January 24, 2022

From DexCom, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022

January 19, 2022

Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...

Via Benzinga

10 Biggest Price Target Changes For Wednesday

January 19, 2022

Raymond James cut DexCom, Inc. (NASDAQ:DXCM) pri...

Via Benzinga

IRTC Stock: 17 Things to Know About iRhythm as Shares Rocket Higher Today

January 10, 2022

Irhythm Technologies (IRTC) stock is rising higher Monday alongside heavy trading of the shares and we know what's behind that movement!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session

January 10, 2022

Gainers Molecular Partners (NASDAQ:MOLN) shares rose 26.6% to $20.9 during Monday's pre-market session. The company's market cap stands at $674.6 million. Apria (...

Via Benzinga

Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data from the Dexcom G7 U.S. Pivotal Trial

January 10, 2022

From DexCom, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022

January 07, 2022

Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:

Via Benzinga

Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference

January 04, 2022

From DexCom, Inc.

Via Business Wire

IBM Artificial Intelligence Supercomputer Watson Has 8 Stock Picks For 2022

December 29, 2021

It’s the time of year that investors consider which stocks to buy and sell to build their portfolio for the next 12 months. Inflati...

Via Benzinga

Even Good Penny Stocks Like Senseonics Aren’t Always Profitable

December 03, 2021

Its latest implanted sensor lasts six months, but SENS stock faces competition from Dexcom, Abbott Labs and potentially one big name in tech.

Via InvestorPlace

Dexcom Announces Upcoming Conference Presentation

November 29, 2021

From DexCom, Inc.

Via Business Wire

3 Reasons This Stock Could 10X in 10 Years

November 18, 2021

This healthcare company isn't done beating the market.

Via The Motley Fool

< Previous 1 2

...

25 26 27 28 29 30 31 32 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.